Results
1 -
10 of
18
(Click
here to explore results)
- New Tools to Interrogate Endocannabinoid Signalling: From Natural Compounds to Synthetic Drugs, Chapter 4 Natural Compounds and Synthetic Drugs to Target Type-2 Cannabinoid (CB2) Receptor. Wolfgang Guba, Marc Nazaré, Uwe Grether
, 2021
, Pages 89-167
- New Tools to Interrogate Endocannabinoid Signalling: From Natural Compounds to Synthetic Drugs, Chapter 3 Natural Compounds and Synthetic Drugs to Target Type-1 Cannabinoid (CB1) Receptor. Christos Iliopoulos-Tsoutsouvas, Markos-Orestis Georgiadis, Lipin Ji, Spyros P. Nikas, Alexandros Makriyannis
, 2021
, Pages 48-88
- Forensic Chemistry of Substance Misuse: A Guide to Drug Control (2), CHAPTER 17 Cannabis and Phytocannabinoids
, 2022
, Pages 220-233
- Forensic Chemistry of Substance Misuse: A Guide to Drug Control (2), CHAPTER 18 Synthetic Cannabinoid Receptor Agonists (SCRAs)
, 2022
, Pages 234-250
- Emerging Drugs and Targets for Parkinson's Disease, CHAPTER 5 Pharmacologic Management of Dopaminergic‐Induced Dyskinesias in Parkinson’s Disease. Mildred D. Gottwald, Michael J. Aminoff
, 2013
, Pages 110-125
- The Misuse of Drugs Act: A Guide for Forensic Scientists, Generic controls: Substance-specific. L. A. King
, 2003
, Pages 25-28
- Emerging Drugs and Targets for Multiple Sclerosis, CHAPTER 11 Cannabinoids as a Therapeutic Approach in Multiple Sclerosis. Gareth Pryce, David Baker
, 2019
, Pages 241-263
- Forensic Chemistry of Substance Misuse: A Guide to Drug Control (2), CHAPTER 6 Nomenclature
, 2022
, Pages 58-67
- New Tools to Interrogate Endocannabinoid Signalling: From Natural Compounds to Synthetic Drugs, Subject Index
, 2021
, Pages 451-457
- Pharmaceutical Formulation: The Science and Technology of Dosage Forms, CHAPTER 2 Hard Capsules in Modern Drug Delivery. S. Stegemann, W. Tian, M. Morgen, S. Brown
, 2018
, Pages 21-51